Call Nathan A, Mevers Joanna Lomas, McElhanon Barbara O, Scheithauer Mindy C
Marcus Autism Center, Children's Healthcare of Atlanta, Emory University School of Medicine.
Emory University School of Medicine.
J Appl Behav Anal. 2017 Apr;50(2):332-344. doi: 10.1002/jaba.379. Epub 2017 Feb 17.
Achieving continence of one's bowel movements is a key step in development and failure to do so leads to many negative consequences. Treatments for encopresis appearing in the literature have employed behavioral strategies; medications such as suppositories, laxatives, or enemas; and in some studies a combination of these approaches. To date, attempts to extend successful treatments for encopresis in typically developing children to those with developmental disabilities have been limited. The current study included three participants diagnosed with developmental disabilities who had a history of encopresis. None of the participants had a continent bowel movement under baseline conditions. Continent bowel movements increased during treatment that included the addition of suppositories to elicit continent bowel movements. Two participants began having independent continent bowel movements (i.e., without requiring suppositories) and medication was successfully faded out for the remaining participant. Treatment took between 13 and 21 days.
实现排便自控是发育过程中的关键一步,无法做到这一点会导致许多负面后果。文献中针对遗粪症的治疗采用了行为策略;栓剂、泻药或灌肠剂等药物;在一些研究中还采用了这些方法的组合。迄今为止,将典型发育儿童成功的遗粪症治疗方法扩展到发育障碍儿童的尝试有限。当前的研究纳入了三名被诊断为发育障碍且有遗粪症病史的参与者。在基线条件下,没有一名参与者能够自主控制排便。在治疗过程中,通过添加栓剂来引发自主排便,自主排便次数增加。两名参与者开始能够独立自主排便(即无需栓剂),其余一名参与者的药物也成功停用。治疗持续了13至21天。